做寿星不做股神
2020-02-07

[666] [666]

@小虎AV：
【專訪瑞德西韋臨牀研發團隊負責人】美國北卡大學教授Ralph Baric團隊曾在2016年負責瑞德西韋的臨牀研發，該藥品目前被寄希望用於治療新冠病毒肺炎。Baric接受梨視頻專訪稱，團隊研發的兩種核苷類藥物均可阻斷冠狀病毒的複製，在小鼠實驗中顯示有效。 $吉利德科學(GILD)$
【專訪瑞德西韋臨牀研發團隊負責人】美國北卡大學教授Ralph Baric團隊曾在2016年負責瑞德西韋的臨牀研發，該藥品目前被寄希望用於治療新冠病毒肺炎。Baric接受梨視頻專訪稱，團隊研發的兩種核苷類藥物均可阻斷冠狀病毒的複製，在小鼠實驗中顯示有效。 $吉利德科學(GILD)$

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet